Manufacturing Cells
Manufacturing Cells
In 50 Words
Or Less
Ordinary production processes allow for a large
number of defects.
Making the switch to work cells can increase
quality assurance by decreasing the number of
interacting variables in a process.
58
TABLE 1
Quality benefit
1. Reduce variation:
a. Product variation
Minimal interprocess waiting exposes nonconformities that can be rectified before they accumulate.
b. Time variation
Limited inventory accumulations put upper limits on process times, thereby reducing throughput time variation.
c. Process/method variation
Closely linked processes leave little latitude for time variation and press for well-defined processes and
methods and operator certification.
Intolerance for process failures and downtime presses for high levels of process maintenance with
upgraded capability and reliability.
Minimal-delay processing raises chances of catching nonconformities at the next process while the audit
trail is fresh and root cause possibilities few.
Intolerance for process failures encourages multifunctional, experienced and expert people to be ready for fact
based problem solving.
Intolerance for failures presses for highly relevant and accurate process documentation; also, much reduced
flow distances, throughput times and organizational entities, along with the elimination of stock rooms and
overall process simplicity, greatly reduce administrative documentation and attendant processing mistakes.
QUALITY PROGRESS
I APRIL 2004 I 59
PROCESS IMPROVEMENT
Cells at Microsoft
And Hallmark Cards
A service industry example of the benefits of
cells took place at Microsoft around 1991. At that
time, Microsoft was buying about 2,000 personal
computers a month because its many software
60
Bad Medicine
Hidden root causes and their much delayed consequences are bad business when they involve PC
acquisition or greeting cards. They can also be bad
medicine when they involve the production of medical devices. Cellular assembly of medical products
creates clear responsibility chains and clean, simple
audit trails. However, medical device production
typically goes from gang to gang, resulting in a confusion of process flow paths.
Consider the production of IV bags, which I
observed at Baxter Internationals North Cove
plant near Asheville, NC. The process starts with
an extruder that forms the bags. Extruded bags
drop onto a moving conveyor belt where one
gangassemblers positioned on either side of the
beltattaches components such as valves and
plugs, and another gang down the line installs
more components, including tubing. Other gangs
further along perform testing, then packaging.
If, for example, a bag is found to have an incorrectly installed valve at the testing stage, attempts to
trace it back to the responsible assembler would run
into finger pointing among the assembly gang. The
problem begs for breaking up the gangs and reorganizing them into cell teams, each with the same
process steps. In that mode, the extruder deals out
bags to each cell team, and from then on, processing
goes from hand to hand within each cell. The first
cell member installs plugs, the next one installs the
valves and so on, creating a one-to-one responsibility chain and audit trail.
The top panel of Figure 1 illustrates the conventional gang to gang way of producing IV bags, and
the lower panel illustrates the cellular alternative.
In each of the three cells, processing is done person
to persontheres no need for a conveyor belt
here. Ideally, each of the cells would have its own
small extruder. But costs rule the day, so the single,
large extruder is used to feed all three of the assemble-test-package cells.
Usually, a cell is U-shaped, serpentine or L-shaped,
as shown here. These configurations, unlike linear
flow lines, put cell team members in close quarters,
TABLE 2
Dispersed
Clustered
16
13
2 years
3 months
Time to market
Virtual Cells
The benefits of introducing a cellular workflow
are applicable across the boardnot just in relatively simple cases of labor intensive assembly through
packaging. The majority of medical devices, pharmaceuticals and food products involve departmentto-department flow patterns in which multiple
IV Bag Production:
Gang-to-Gang vs. Cellular
FIGURE 1
Extruder
Assembly
gang 1
Assembly
gang 2
Testers
Packaging
Extruder
QUALITY PROGRESS
I APRIL 2004 I 61
PROCESS IMPROVEMENT
FIGURE 2
Shop-to-shop:
192 value
adding steps;
traceback
impossible
One-to-one
flows: three
value adding
steps per
process flow;
clear traceback
62
Melt
Cast
1
2
3
4
Process/
team
A team
B team
C team
D team
Mill
1
2
3
4
Melt
A
B
C
D
1
2
3
4
Continuous
cast
A
B
C
D
Rolling
mill
A
B
C
D
Please
comment
If you would like to comment on this article, please post your
remarks on the Quality Progress Discussion Board at
http://www.asq.org, or e-mail them to [email protected].
Reports
Standard or custom reports are easily obtained and viewed, providing real-time
information across your entire enterprise 24/7.
e-QMS
caWeb
Audit Master
Audit Master Online
Document Control
Corrective Action (CA/PA)
Training Manager
Calibration Recall
Cost of Quality
Maintenance Log Pro
Supplier Rating Manager
Self Assessment Utility
QUALITY PROGRESS
I APRIL 2004 I 63